
Boneprox drives innovation in digital dentistry and medical technology since 2013. With a dedicated team of medical specialists, business developers, and AI experts, Boneprox creates effective and secure solutions addressing today's and tomorrow's challenges in dental and healthcare. Their flagship products include Konekta, a tele-diagnostic network for dentists, and Nanok, an AI solution for dental radiography analysis, enhancing diagnostic precision and patient care. Boneprox is positioned as a leader in the Scandinavian market, connecting dental and healthcare sectors through advanced technology.

Boneprox drives innovation in digital dentistry and medical technology since 2013. With a dedicated team of medical specialists, business developers, and AI experts, Boneprox creates effective and secure solutions addressing today's and tomorrow's challenges in dental and healthcare. Their flagship products include Konekta, a tele-diagnostic network for dentists, and Nanok, an AI solution for dental radiography analysis, enhancing diagnostic precision and patient care. Boneprox is positioned as a leader in the Scandinavian market, connecting dental and healthcare sectors through advanced technology.
Founded: 2013
Headquarters: Gothenburg, Sweden
Core products: Konekta (telediagnostics), Nanok (AI dental X‑ray analysis), KonektED (education)
Employees (reported): Approximately 17–60 (company-stated figures vary)
Notable investors/supporters: BioGaia, BackingMinds, Research Council of Norway (grant)
Digital dentistry, dental imaging analysis, telediagnostics and dental education.
2013
Dental technology; healthtech
3700000.00
Total funding figure reported; specific round details not provided in evidence.
BackingMinds invested in October 2019 (date approximate as reported).
11,000,000 SEK
SEK 11 million awarded as a research grant for an AI dentistry project.
11,000,000 SEK
Company announced a capital injection naming BioGaia and BackingMinds as investors; amount reported as 11 MSEK in company communication.
“Boneprox has received investment and grant funding from corporate and public backers including BioGaia, BackingMinds and the Research Council of Norway.”